Metabolomic profile as a biomarker in early breast cancer patients candidate to neoadjuvant therapy

被引:0
|
作者
Martini, V. [1 ]
Ruffilli, B. [2 ]
Di Lascio, S. [1 ]
D'Avanzo, F. [1 ]
Rossi, V. [1 ]
Gobbato, S. [2 ]
Vezzoli, F. [2 ]
Negrini, L. [2 ]
Alsati, R. [2 ]
Ben Ayed, R. [2 ]
Tarantino, G. [3 ]
Guarneri, V. [4 ]
Griguolo, G. [4 ]
Boldorini, R. L. [2 ]
Branni, C. [2 ]
Matera, L. [2 ]
Sala, N. [2 ]
Barberis, E. [2 ]
Manfredi, M. [2 ]
Gennari, A. [2 ]
机构
[1] AOU Maggiore Carita, Dept Oncol, Novara, Italy
[2] Univ Piemonte Orientale, Translat Med, Novara, Italy
[3] Pharmanutra Spa, Pisa, Italy
[4] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
关键词
D O I
10.1016/j.ejca.2024.113874
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
308 (PB-12
引用
收藏
页码:115 / 115
页数:1
相关论文
共 50 条
  • [41] Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
    Ida Skarping
    Daniel Förnvik
    Uffe Heide-Jørgensen
    Hanna Sartor
    Per Hall
    Sophia Zackrisson
    Signe Borgquist
    Cancer Causes & Control, 2021, 32 : 251 - 260
  • [42] Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
    Skarping, Ida
    Fornvik, Daniel
    Heide-Jorgensen, Uffe
    Sartor, Hanna
    Hall, Per
    Zackrisson, Sophia
    Borgquist, Signe
    CANCER CAUSES & CONTROL, 2021, 32 (03) : 251 - 260
  • [43] Biomarker Profile in Metastatic Breast Cancer
    Slodkowska, Elzbieta
    Abdalahad, Nagham
    Lu, Fang-I
    Han, Guangming
    Hanna, Wedad
    Nofech-Mozes, Sharon
    LABORATORY INVESTIGATION, 2015, 95 : 67A - 67A
  • [44] Biomarker Profile in Metastatic Breast Cancer
    Slodkowska, Elzbieta
    Abdalahad, Nagham
    Lu, Fang-I
    Han, Guangming
    Hanna, Wedad
    Nofech-Mozes, Sharon
    MODERN PATHOLOGY, 2015, 28 : 67A - 67A
  • [45] How previous treatment changes the metabolomic profile in patients with metastatic breast cancer
    Juliane Nees
    Simon Schafferer
    Baowen Yuan
    Quiqong Tang
    Matthias Scheffler
    Andreas Hartkopf
    Michael Golatta
    Andreas Schneeweiß
    Barbara Burwinkel
    Markus Wallwiener
    Archives of Gynecology and Obstetrics, 2022, 306 : 2115 - 2122
  • [46] How previous treatment changes the metabolomic profile in patients with metastatic breast cancer
    Nees, Juliane
    Schafferer, Simon
    Yuan, Baowen
    Tang, Quiqong
    Scheffler, Matthias
    Hartkopf, Andreas
    Golatta, Michael
    Schneeweiss, Andreas
    Burwinkel, Barbara
    Wallwiener, Markus
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (06) : 2115 - 2122
  • [47] Impact of immunohistochemical profile changes following neoadjuvant therapy in the treatment of breast cancer
    Candas, Gabriela
    Garcia, Alejandra
    Delfina Ocampo, Maria
    Korbenfeld, Ernesto
    Daniel Vuoto, H.
    Isetta, Juan
    Cagorno, Lucas
    Gonzalez Zimmermann, Agustina
    Sigal, Marca
    Acevedo, Santiago
    Berwart, Julia
    Naveira, Martin
    Bemi, Agustina
    Luis Uriburu, Juan
    ECANCERMEDICALSCIENCE, 2021, 15
  • [48] Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
    Holanek, Milos
    Selingerova, Iveta
    Fabian, Pavel
    Coufal, Oldrich
    Zapletal, Ondrej
    Petrakova, Katarina
    Kazda, Tomas
    Hrstka, Roman
    Poprach, Alexandr
    Zvarikova, Maria
    Bilek, Ondrej
    Svoboda, Marek
    DIAGNOSTICS, 2022, 12 (07)
  • [49] Defining the metabolomic profile related with cardiotoxicity in patients with breast cancer treated with anthracyclines
    Ricci, Sara Jane
    Onnis, Carlotta
    Agus, Elena
    Aneris, Federico
    Demelas, Roberta
    Peccianti, Antonella
    Pettinau, Antonio
    Pinna, Gabriele
    Zanda, Greca
    Noto, Antonio
    Barberini, Luigi
    Deidda, Martino
    Atzori, Francesco
    Madeddu, Clelia
    Scartozzi, Mario
    Mercuro, Giuseppe
    Dessalvi, Christian Cadeddu
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N20 - N20
  • [50] Current Status of Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer
    Tomás Reinert
    Rodrigo Gonçalves
    Matthew J. Ellis
    Current Treatment Options in Oncology, 2018, 19